Developing advanced tools to analyze genomic data
Next Generation Computational Tools for Functional Genomics
['FUNDING_R01'] · DANA-FARBER CANCER INST · NIH-10904695
This study is working on new computer tools to help scientists better understand how our genes work in health and disease, especially using advanced techniques that look at individual cells, so they can find clearer answers about gene activity and regulation.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | DANA-FARBER CANCER INST (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10904695 on ClinicalTrials.gov |
What this research studies
This research focuses on creating next-generation computational tools to better analyze genomic data, particularly in understanding how genes function in health and disease. It addresses the challenges posed by new technologies and complex biological questions, especially in single-cell RNA sequencing and ATAC sequencing. By developing new algorithms and methodologies, the project aims to improve the accuracy and efficiency of data analysis in functional genomics, ultimately leading to better insights into gene regulation and activity.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with genetic conditions or diseases where genomic analysis could provide insights into their condition.
Not a fit: Patients with conditions that do not involve genomic factors or those not interested in genetic analysis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise understanding of genetic factors in diseases, potentially improving diagnosis and treatment options for patients.
How similar studies have performed: Previous research has shown success in developing computational tools for genomic analysis, indicating that this approach has a strong foundation.
Where this research is happening
BOSTON, UNITED STATES
- DANA-FARBER CANCER INST — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: IRIZARRY, RAFAEL ANGEL — DANA-FARBER CANCER INST
- Study coordinator: IRIZARRY, RAFAEL ANGEL
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.